(1)
Yukio NAKAMURA; Takako SUZUKI; Hideshi YAMAZAKI; Hiroyuki KATO. Tofacitinib Versus Non-Tumor Necrosis Factor Biologics for Patients With Active Rheumatoid Arthritis. Archives of Rheumatology 2018, 33, 154-159.